3,522 Shares in iShares Biotechnology ETF $IBB Acquired by Nikulski Financial Inc.

Nikulski Financial Inc. acquired a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB) during the 4th quarter, Holdings Channel.com reports. The firm acquired 3,522 shares of the financial services provider’s stock, valued at approximately $594,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Darwin Wealth Management LLC purchased a new stake in shares of iShares Biotechnology ETF in the 2nd quarter worth $25,000. Ashton Thomas Securities LLC purchased a new position in shares of iShares Biotechnology ETF during the third quarter valued at $36,000. Parkside Financial Bank & Trust increased its stake in shares of iShares Biotechnology ETF by 48.6% during the third quarter. Parkside Financial Bank & Trust now owns 266 shares of the financial services provider’s stock valued at $38,000 after buying an additional 87 shares during the period. Close Asset Management Ltd raised its holdings in shares of iShares Biotechnology ETF by 25.5% in the third quarter. Close Asset Management Ltd now owns 345 shares of the financial services provider’s stock valued at $50,000 after acquiring an additional 70 shares in the last quarter. Finally, Founders Financial Alliance LLC raised its holdings in shares of iShares Biotechnology ETF by 605.7% in the third quarter. Founders Financial Alliance LLC now owns 374 shares of the financial services provider’s stock valued at $54,000 after acquiring an additional 321 shares in the last quarter. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Stock Up 4.3%

NASDAQ:IBB opened at $168.85 on Wednesday. iShares Biotechnology ETF has a 1-year low of $107.43 and a 1-year high of $179.64. The company has a 50-day moving average of $170.97 and a 200 day moving average of $164.70.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, March 20th. Stockholders of record on Tuesday, March 17th were issued a $0.1218 dividend. The ex-dividend date was Tuesday, March 17th. This represents a $0.49 annualized dividend and a dividend yield of 0.3%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.